Promising Results For Glivec In CML Continue, FDA Grants Priority Review
High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I
Wilms’ Tumor Survivors At High Risk Of Heart Failure
Cancer Pain Treatment Guide Published By NCCN, ACS
Without Advance Directives, Families Prolong Treatment
Long-Term Estrogen Use May Increase Ovarian Cancer Risk
Natural Substance Blocks Androgen Activity In Vitro
NCI-Approved Clinical Trials Listed For Month Of March
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
